carbamylhydrazine has been researched along with mofegiline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bey, P; Cremer, G; Danzin, C; McDonald, IA; Palfreyman, MG; Zreika, M | 1 |
| Deng, Y; Yu, PH | 1 |
1 trial(s) available for carbamylhydrazine and mofegiline
| Article | Year |
|---|---|
Haloallylamine inhibitors of MAO and SSAO and their therapeutic potential.
Topics: Allyl Compounds; Amine Oxidase (Copper-Containing); Animals; Butylamines; Drug Evaluation; Humans; Male; Monoamine Oxidase Inhibitors; Oxidoreductases Acting on CH-NH Group Donors; Parkinson Disease; Propylamines; Rats; Rats, Sprague-Dawley; Semicarbazides | 1994 |
1 other study(ies) available for carbamylhydrazine and mofegiline
| Article | Year |
|---|---|
Assessment of the deamination of aminoacetone, an endogenous substrate for semicarbazide-sensitive amine oxidase.
Topics: Acetone; Allyl Compounds; Amine Oxidase (Copper-Containing); Benzylamines; Butylamines; Catalysis; Chromatography, High Pressure Liquid; Clorgyline; Deamination; Enzyme Inhibitors; Humans; Kinetics; Monoamine Oxidase Inhibitors; Phenylenediamines; Pyruvaldehyde; Selegiline; Semicarbazides; Umbilical Arteries | 1999 |